Neurokinin pathway antagonists for vasomotor symptoms in women with breast cancer: focus on elinzanetant and fezolinetant

Vasomotor symptoms (VMS) have a major impact on quality-of-life in women with hormone receptor–positive breast cancer receiving adjuvant endocrine therapy. As menopause hormone therapy is contraindicated in this setting, effective non-hormonal treatment options are urgently needed. We performed a fo...

Description complète

Détails bibliographiques

Auteurs principaux:	Katarzyna Pogoda, Luca Arecco, Matteo Lambertini
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2026-08-01
Collection:	Breast
Sujets:	Vasomotor symptoms Hot flashes Breast cancer Endocrine therapy Neurokinin receptor antagonist Elinzanetant
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S0960977626001220
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!